Data On the Use of Interferon Alfa-n3 in the Treatment of Multiple Sclerosis Presented At the XVII World Congress of Neurology Meeting
(Business Wire)Interferon Sciences, Inc. announced that a poster reporting on a retrospective evaluation entitled, ~~~Interferon alfa-n3 Reduces Enhancing Gadolinium Brain Lesions in Multiple Sclerosis~~~ was presented at the XVII World Congress of Neurology Meeting in London, by Professor William Sheremata, Chief of the Multiple Sclerosis/Neuroimmunology Center of the University of Miami School of Medicine.- Jun 25 9:17 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010625/2305.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines